BioMarin Pharmaceutical Story Overview

BMRN -- USA Stock  

USD 98.15  1.26  1.27%

Macroaxis does not monitor all media channels or aggregates social signals for BioMarin Pharmaceutical. But even though we do not provide professional-grade financial sentiment analysis on BioMarin Pharmaceutical, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for BioMarin Pharmaceutical. Check also BioMarin Pharmaceutical Hype Analysis, BioMarin Pharmaceutical Correlation and BioMarin Pharmaceutical Performance.
Bona fide gift to Robert Baffi of 2675 shares of BioMarin Pharmaceutical subject to Section 16
Filed transaction by Biomarin Pharmaceutical I officer. Exempt bona fide gift subject to Rule 16b-3

BioMarin Pharmaceutical Inc insider trading alert for gift of common stock by Robert Baffi, EVP Technical Operations, on January 3, 2018. This event was filed by Biomarin Pharmaceutical I with SEC on 2016-03-07. Statement of changes in beneficial ownership - SEC Form 4. Robert Baffi is currently serves as executive vp of technical operations of BioMarin Pharmaceutical

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price decrease.The overall trading delta against the next closing price was 1.91% . The overall trading delta when the story was published against the current closing price is 7.73% .

Similar stores for BioMarin Pharmaceutical

a day ago at www.macroaxis.com 
Sale by Davis George Eric of 12000 shares of BioMarin Pharmaceutical
Macroaxis News
Filed transaction by Biomarin Pharmaceutical I officer. General open market or private sale of non-derivative or derivative security
BioMarin Pharmaceutical Inc. Shares Sold by Highland Capital Management LPnews
Baseball Daily NewsMaking Headlines Investors Zeroing in on BioMarin Pharmaceutical Inc. The Coin GuildZacks Investment Research Upgrades BioMarin Pharmaceutical to Hold XNewsPressFull coverage
Arrowgrass Capital Partners US LP Has 32.38 Million Stake in BioMarin Pharmaceutical Inc.news
Fairfield CurrentUS Bancorp DE Raises Stake in BioMarin Pharmaceutical Inc. Marea Informative 25200 Shares in BioMarin Pharmaceutical Inc. Purchased by Aristotle Atlantic Partners LLC XNewsPressFull coverage
over a week ago at www.macroaxis.com 
Sale by Elaine Heron of 1000 shares of BioMarin Pharmaceutical
Macroaxis News
Filed transaction by Biomarin Pharmaceutical I director. General open market or private sale of non-derivative or derivative security
over a week ago at http://xnewspress.com 
BioMarin Pharmaceutical Inc. Stake Increased by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.
news
XNewsPressFull coverage
over two weeks ago at http://pressoracle.com 
BioMarin Pharmaceutical Inc. Insider Sells 2487500.00 in Stock
news
PressOracleFull coverage
over two weeks ago at www.macroaxis.com 
Sale by Henry Fuchs of 12500 shares of BioMarin Pharmaceutical
Macroaxis News
Filed transaction by Biomarin Pharmaceutical I officer. General open market or private sale of non-derivative or derivative security
over three weeks ago at http://pressoracle.com 
American Century Companies Inc. Sells 235479 Shares of BioMarin Pharmaceutical Inc.
news
PressOracleInsider Selling at BioMarin Pharmaceutical Fairfield CurrentAs Biomarin Pharmaceutical Stock Rose, Venbio Select Advisor Lifted Holding by 114.29 Million Zebra ... The Cardinal Weekly Full coverage
over three weeks ago at http://www.wallstreetinvestorplace.com 
Sale by Alan Lewis of 4200 shares of BioMarin Pharmaceutical
news
Filed transaction by Biomarin Pharmaceutical I director. General open market or private sale of non-derivative or derivative security
over three weeks ago at http://richlandstandard.com 
BioMarin Pharmaceutical Inc. Sales Change of 0.19778 YoY
news
Richland StandardTraders Buy Shares of BioMarin Pharmaceutical on Weakness Fairfield CurrentBioMarin Pharmaceutical Inc Risk Points versus Health Care CML NewsPremarket analyst action - healthcare Seeking AlphaFull coverage
over a month ago at http://www.thecoinguild.com 
Market Review Investors Keen on BioMarin Pharmaceutical Inc. as it Makes Headlines With Moves
news
The Coin GuildIthaka Group Lifted Its Biomarin Pharmaceutical Holding by 4.83 Million Aureus Asset Management ... The EN BulletinPalo Alto Investors Raised Its Biomarin Pharmaceutical Position by 3.86 Million As Sysco Shares ... Z TribuneFull coverage
Exercise or conversion by Lawlis V Bryan of 2150 shares of BioMarin Pharmaceutical subject to Rule 16b-3news
Filed transaction by Biomarin Pharmaceutical I director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three months ago at http://www.zacks.com 
Exercise or conversion by Bienaime Jean Jacques of 18750 shares of BioMarin Pharmaceutical subject to Rule 16b...
zacks News
Filed transaction by Biomarin Pharmaceutical I director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Beta

Beta Comparative Analysis

  Beta 
      BioMarin Pharmaceutical Comparables 
BioMarin Pharmaceutical is currently under evaluation in beta category among related companies. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.

Peers

BioMarin Pharmaceutical Related Equities

DNLI  3.52 %   
0%
71.0%
EARS  2.85 %   
0%
57.0%
DVAX  1.72 %   
0%
34.0%
NK  0.69 %   
0%
13.0%
DMPI  0.06 %   
1.0%
0%
DOVA  0.45 %   
9.0%
0%
CO  2.37 %   
47.0%
0%
DRNA  3.39 %   
68.0%
0%
EDGE  4.04 %   
81.0%
0%
ECYT  4.95 %   
100.0%
0%
Check also BioMarin Pharmaceutical Hype Analysis, BioMarin Pharmaceutical Correlation and BioMarin Pharmaceutical Performance. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com